Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Print1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Infect Dis1
Search Results
Sort by
- BookHealth disparities in the United States : social class, race, ethnicity, and health. Second edition.Donald A. Barr, MD, PhD, Professor, Department of Pediatrics, and (by courtesy) in the Graduate School of Education, Stanford University, Stanford, California.Summary: "The health care system in the United States has been called the best in the world. Yet wide health disparities persist between different social groups, and many Americans suffer from poorer health than people in other developed countries. Donald A. Barr's Health Disparities in the United States explores how socioeconomic status, race, and ethnicity interact with socioeconomic inequality to create and perpetuate these health disparities."--Page 4 of cover.
Contents:
Introduction to the social roots of health disparities
What is "health"? how should we define it? how should we measure it?
The relationship between socioeconomic status and health, or, "they call it 'poor health' for a reason"
Understanding how low social status leads to poor health
Race, ethnicity, and health
Race/ethnicity, socioeconomic status, and health : which is more important in affecting health status?
Children's health disparities
All things being equal ... does race/ethnicity affect how physicians treat patients?
Why does race/ethnicity affect the way physicians treat patients?
When, if ever, is it appropriate to use a patient's race/ethnicity to guide medical decisions?
What should we do to reduce health disparities? - ArticleDouglas RG, Bentley DW, Brandriss MW.J Infect Dis. 1977 Dec;136 Suppl:S526-32.Antibody responses and side effects to bivalent influenza A virus vaccines from three different manufacturers, containing 200 or 400 chick cell-agglutinating (CCA) units each of A/New Jersey/8/76 (Hsw1N1) and A/Victoria/3/75 (H3N2) antigens, were evaluated in 234 ambulatory elderly and chronically ill volunteers in a placebo-controlled, doubld-blind study. Systemic reactions did not occur significantly more often among recipients of vaccine than among volunteers who received placebo. Local reactions to vaccines were observed but were mild, transient, and well tolerated. Occurrence of preexisting antibody to each antigen was common. Titers of antibody to A/New Jersey/8/76 (Hsw1N1) antigen of greater than or equal to 1:40 occurred after immunization in 94%-100% of volunteers receiving vaccines and in 66% of the placebo recipients. Titers of antibody to A/Victoria/3/75 (H3N2) antigen of greater than or equal to 1:40 occurred in 53%-85% of vaccine recipients compared with 34% of those in the placebo group. Thus, bivalent split-product and whole-virus influenza I vaccines containing 200/200 or 400/400 CCA units of the two antigens appeared to be nearly equivalent in incidence and severity of side effects and antibody responses in recipients.